Very recently, an FTD mouse knock-in model carrying a Triggering Receptor Expressed On Myeloid Cells (TREM2) mutation, showed a significant reduction in glucose metabolism, providing further support to the link between FTD and glucose metabolism [18]. The gene discussed is TREM2; the disease is frontotemporal dementia.